Finance

Lists
Why is HALEOSLABS down 3.21%?
Dive Deeper
HALEOSLABS:NSE
Haleos Labs Ltd
₹1,580.00
-3.21%
(-52.40) 1D
Nov 19, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HALEOSLABS...
Open
₹1,632.40
High
₹1,639.30
Low
₹1,570.00
Mkt. cap
4.78B
Avg. vol.
1.78K
Volume
594.00
Dividend
0.09%
Quarterly dividend
₹0.37
Ex-dividend date
Sep 23, 2026
P/E ratio
36.87
52-wk high
₹1,774.00
52-wk low
₹1,091.10
EPS
₹42.85
No. of employees
611
Open
₹1,632.40
High
₹1,639.30
Low
₹1,570.00
Mkt. cap
4.78B
Avg. vol.
1.78K
Volume
594.00
Dividend
0.09%
Quarterly dividend
₹0.37
Ex-dividend date
Sep 23, 2026
P/E ratio
36.87
52-wk high
₹1,774.00
52-wk low
₹1,091.10
EPS
₹42.85
No. of employees
611
News stories
From web sources and news partners
About Haleos Labs Ltd
CEO-
Employees611
Founded1990
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
947.83M
751.39M
729.42M
914.60M
Cost of goods sold
611.41M
450.40M
421.16M
593.04M
Cost of revenue
611.41M
450.40M
421.16M
593.04M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
166.96M
173.76M
175.49M
177.16M
Operating expense
235.04M
278.22M
259.50M
280.00M
Total operating expenses
846.44M
728.61M
680.66M
873.04M
Operating income
101.39M
22.78M
48.76M
41.56M
Other non operating income
1.83M
412.00K
4.63M
-
EBT including unusual items
87.78M
9.06M
34.40M
20.08M
EBT excluding unusual items
87.78M
16.89M
34.40M
20.08M
Income tax expense
21.29M
5.62M
15.99M
2.49M
Effective tax rate
24.25%
62.01%
46.50%
12.39%
Other operating expenses
28.98M
64.98M
41.56M
60.38M
Net income
66.17M
4.36M
26.47M
32.55M
Net profit margin
6.98%
0.58%
3.63%
3.56%
Earnings per share
-
-
-
-
Interest and investment income
-
3.72M
-
-
Interest expense
-15.44M
-10.96M
-19.00M
-21.47M
Net interest expenses
-15.44M
-7.25M
-19.00M
-21.47M
Depreciation and amortization charges
39.10M
38.49M
42.44M
42.46M
EBITDA
137.21M
59.82M
87.43M
84.01M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps